Nawid Albinger

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Nawid Albinger, Rita Pfeifer, Marcus Nitsche et al. · Blood Cancer Journal · 2022 · 112 citations · Full text

Life Sciences, Immunology, Oncology +17

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells

Tobias Bexte, Nawid Albinger, Ahmad Al Ajami et al. · Nature Communications · 2024 · 72 citations · Full text

Life Sciences, Immunology, Molecular Genetics +12

Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia

Nawid Albinger, Sabine Müller, Julia Kostyra et al. · Bone Marrow Transplantation · 2024 · 38 citations · Full text

Life Sciences, Biotechnology, Immunology +17

CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML

Nawid Albinger, Tobias Bexte, Leon Buchinger et al. · Blood · 2022 · 22 citations

Medicine, Molecular Genetics, Oncology +16

Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis

Jenny Roesler, Daniel Spitzer, Xiaoxiong Jia et al. · Neuro-Oncology · 2024 · 12 citations · Full text

Medicine, Cancer Biology, Oncology +17